Daniel Powell

Biography
Dr. Daniel J. Powell Jr. is a leading translational immunologist whose work has helped shape the development of cancer immunotherapy, particularly for gynecologic malignancies and other solid tumors. As a faculty member at Penn Medicine, he has played a central role in advancing immune-based approaches that move beyond conventional treatment strategies, with an emphasis on therapies that can be both mechanistically rational and clinically actionable. His lab is known for combining rigorous basic science with a clear translational mission, creating a research program that is deeply rooted in tumor immunology while remaining focused on the needs of patients with difficult-to-treat cancers. A major strength of Dr. Powell’s program is its breadth across the immunotherapy pipeline. His team has contributed to the development and refinement of adoptive cell therapies, including CAR T cell and T cell receptor-based strategies, as well as cancer vaccination and other immune-directed approaches designed to improve anti-tumor activity in solid tumors. This work has been especially important in cancers such as ovarian and other gynecologic malignancies, where durable responses to immunotherapy remain challenging and where new biological insights are urgently needed. By pursuing both discovery and translation, the lab has helped define new therapeutic concepts while also testing how those concepts can be brought into the clinic.